Company record
Bactheravax B.V.
- B.V.
Signals
2 on record
- EPO patentsPatent
Patent publication NL4000040B1 by BACTHERAVAX B.V: FUSOBACTERIUM NUCLEATUM-BASED CANCER VACCINES.
EPO patentsRelevance21
Watch · 80% confidence
- EPO patentsPatent
Patent publication WO2026206149A1 by BACTHERAVAX B.V.: FUSOBACTERIUM NUCLEATUM-BASED CANCER VACCINES.
EPO patentsRelevance21
Watch · 80% confidence